The Opioid Industry's Golden Opportunity: A Cautionary Tale The opioid epidemic has ravaged communities across America, leaving a trail of devastation and despair.
Amidst this wreckage, one pharmaceutical company, Indivior Pharmaceuticals, is poised to capitalize on the crisis, with its profits surging by 108% as it positions itself as a leading treatment provider for Opioid Use Disorder (OUD).
The industry's long standing criticism – prioritizing profits over people – is starkly illustrated by the opioid crisis, which has claimed hundreds of thousands of lives since 1999.